Abstract
OBJECTIVES: This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City. METHODS: We analyzed temporal trends in HIV seroprevalence from 1991 through 1996 in 5 studies of injecting drug users recruited from a detoxification program, a methadone maintenance program, research storefronts in the Lower East Side and Harlem areas, and a citywide network of sexually transmitted disease clinics. A total of 11,334 serum samples were tested. RESULTS: From 1991 through 1996, HIV seroprevalence declined substantially among subjects in all 5 studies: from 53% to 36% in the detoxification program, from 45% to 29% in the methadone program, from 44% to 22% at the Lower East Side storefront, from 48% to 21% at the Harlem storefront, and from 30% to 21% in the sexually transmitted disease clinics (all P < .002 by chi 2 tests for trend). CONCLUSIONS: The reductions in HIV seroprevalence seen among injecting drug users in New York City from 1991 through 1996 indicate a new phase in this large HIV epidemic. Potential explanatory factors include the loss of HIV-seropositive individuals through disability and death and lower rates of risk behavior leading to low HIV incidence.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Caussy D., Weiss S. H., Blattner W. A., French J., Cantor K. P., Ginzburg H., Altman R., Goedert J. J. Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs. AIDS Res Hum Retroviruses. 1990 Dec;6(12):1459–1467. doi: 10.1089/aid.1990.6.1459. [DOI] [PubMed] [Google Scholar]
- Chang H. G., Morse D. L., Noonan C., Coles B., Mikl J., Rosen A., Putnam D., Smith P. F. Survival and mortality patterns of an acquired immunodeficiency syndrome (AIDS) cohort in New York State. Am J Epidemiol. 1993 Sep 1;138(5):341–349. doi: 10.1093/oxfordjournals.aje.a116864. [DOI] [PubMed] [Google Scholar]
- Des Jarlais D. C., Friedman S. R., Hopkins W. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med. 1985 Nov;103(5):755–759. doi: 10.7326/0003-4819-103-5-755. [DOI] [PubMed] [Google Scholar]
- Des Jarlais D. C., Friedman S. R., Novick D. M., Sotheran J. L., Thomas P., Yancovitz S. R., Mildvan D., Weber J., Kreek M. J., Maslansky R. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989 Feb 17;261(7):1008–1012. doi: 10.1001/jama.261.7.1008. [DOI] [PubMed] [Google Scholar]
- Des Jarlais D. C., Friedman S. R., Sotheran J. L., Wenston J., Marmor M., Yancovitz S. R., Frank B., Beatrice S., Mildvan D. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA. 1994 Jan 12;271(2):121–127. [PubMed] [Google Scholar]
- Des Jarlais D. C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., Jose B., Friedman S. R. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996 Oct 12;348(9033):987–991. doi: 10.1016/s0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
- Eisenhandler J., Drucker E. Opiate dependency among the subscribers of a New York area private insurance plan. JAMA. 1993 Jun 9;269(22):2890–2891. [PubMed] [Google Scholar]
- Friedman S. R., Des Jarlais D. C., Sotheran J. L., Garber J., Cohen H., Smith D. AIDS and self-organization among intravenous drug users. Int J Addict. 1987 Mar;22(3):201–219. doi: 10.3109/10826088709027425. [DOI] [PubMed] [Google Scholar]
- Holmberg S. D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996 May;86(5):642–654. doi: 10.2105/ajph.86.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mariotto A. B., Mariotti S., Pezzotti P., Rezza G., Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol. 1992 Feb 15;135(4):428–437. doi: 10.1093/oxfordjournals.aje.a116303. [DOI] [PubMed] [Google Scholar]
- Marmor M., Titus S., Harrison C., Cord-Cruz E. A., Shore R. E., Vogler M., Krasinski K., Mildvan D., Des Jarlais D. C. Weight loss associated with HIV seroconversion among injection-drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):514–518. doi: 10.1097/00042560-199608150-00012. [DOI] [PubMed] [Google Scholar]
- Orr M. F., Glebatis D., Friedmann P., des Jarlais D. C., Prevots D. R. Incidence of HIV infection in a New York City methadone maintenance treatment program. JAMA. 1996 Jul 10;276(2):99–99. doi: 10.1001/jama.276.2.99b. [DOI] [PubMed] [Google Scholar]
- Prevots D. R., Allen D. M., Lehman J. S., Green T. A., Petersen L. R., Gwinn M. Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993. Am J Epidemiol. 1996 Apr 1;143(7):733–742. doi: 10.1093/oxfordjournals.aje.a008807. [DOI] [PubMed] [Google Scholar]
- Schoenbaum E. E., Hartel D. M., Gourevitch M. N. Needle exchange use among a cohort of injecting drug users. AIDS. 1996 Dec;10(14):1729–1734. doi: 10.1097/00002030-199612000-00018. [DOI] [PubMed] [Google Scholar]
- Selwyn P. A., Feiner C., Cox C. P., Lipshutz C., Cohen R. L. Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City. AIDS. 1987 Dec;1(4):247–254. [PubMed] [Google Scholar]
